![Sophie Baratte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sophie Baratte
Corporate Officer/Principal chez
Agile Capital Markets SAS
Profil
Currently, Sophie Baratte is Chief Executive Officer & Director at Cellnovo Group SA since 2016 and Partner at Agile Capital Markets SAS. Formerly, Dr. Baratte was Chief Executive Officer & Director at Cellnovo Ltd. and Independent Director at Stentys SA from 2017 to 2021.
Education includes an MBA from École des Hautes Études Commerciales de Paris and a doctorate from the University of Compiègne.
Postes actifs de Sophie Baratte
| Sociétés | Poste | Début |
|---|---|---|
Agile Capital Markets SAS | Corporate Officer/Principal | - |
Anciens postes connus de Sophie Baratte
| Sociétés | Poste | Fin |
|---|---|---|
| STENTYS | Directeur/Membre du Conseil | 01/03/2021 |
Cellnovo Ltd.
 Cellnovo Ltd. Medical SpecialtiesHealth Technology Manufactures diabetes management devices | Directeur Général | - |
| CELLNOVO | Directeur Général | - |
Formation de Sophie Baratte
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Engages in development and production of coronary stents | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
University of Compiègne
 University of Compiègne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Manufactures diabetes management devices | Health Technology |
Agile Capital Markets SAS |
Choisissez Zonebourse 
